IMMUNOGLOBULIN G4 RELATED DISEASE
Clinical trials for IMMUNOGLOBULIN G4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN G4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN G4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame rare inflammatory disease
Disease control Recruiting nowThis phase 3 study tests whether the oral drug rilzabrutinib can prevent disease flares in adults with active IgG4-related disease, a rare condition causing swelling and organ damage. About 124 participants will receive either rilzabrutinib or a placebo for 52 weeks, alongside st…
Matched conditions: IMMUNOGLOBULIN G4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
New registry aims to unlock secrets of rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information on people with rare diseases like amyloidosis, sarcoidosis, and Gaucher disease. Researchers will track patients' health over time, including their symptoms, treatments, and outcomes. The goal is to improve diagnosis …
Matched conditions: IMMUNOGLOBULIN G4 RELATED DISEASE
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC